- Home
- / Threshold Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Threshold Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 23, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 62.0K | 5.9M | 12.5M | 14.7M | 76.9M | |||
| Revenue growth, % | 9362.9% | 113.0% | 17.8% | 422.4% | -100.0% | |||
| General and administrative expense | 5.7M | 7.1M | 9.2M | 10.1M | 9.7M | 7.8M | 26.7M | 34.1M |
| Operating expense total | 30.1M | 25.9M | 38.5M | 46.0M | 50.0M | 24.4M | ||
| EBIT | (30.0M) | (20.0M) | (26.0M) | (31.3M) | 26.9M | (24.4M) | ||
| EBIT margin, % | -48445.2% | -340.9% | -208.3% | -212.3% | 35.0% | |||
| Interest income | 25.0K | 80.0K | ||||||
| Interest expense | 136.0K | 121.0K | 125.0K | 147.0K | 1.0M | 434.0K | ||
| Pre tax profit | (28.2M) | (21.8M) | 43.8M | (24.1M) | (104.9M) | (83.0M) | ||
| Income tax expense | 202.0K | (202.0K) | 5.0K | |||||
| Net Income | (25.7M) | (71.1M) | (28.4M) | (21.6M) | 43.8M | (24.1M) |